These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
567 related articles for article (PubMed ID: 32817139)
1. Lysine Demethylase KDM6A in Differentiation, Development, and Cancer. Tran N; Broun A; Ge K Mol Cell Biol; 2020 Sep; 40(20):. PubMed ID: 32817139 [TBL] [Abstract][Full Text] [Related]
2. KDM6 demethylase independent loss of histone H3 lysine 27 trimethylation during early embryonic development. Shpargel KB; Starmer J; Yee D; Pohlers M; Magnuson T PLoS Genet; 2014 Aug; 10(8):e1004507. PubMed ID: 25101834 [TBL] [Abstract][Full Text] [Related]
3. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. Chang S; Yim S; Park H Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981 [TBL] [Abstract][Full Text] [Related]
4. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Hong S; Cho YW; Yu LR; Yu H; Veenstra TD; Ge K Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18439-44. PubMed ID: 18003914 [TBL] [Abstract][Full Text] [Related]
5. UTX Mutations in Human Cancer. Wang L; Shilatifard A Cancer Cell; 2019 Feb; 35(2):168-176. PubMed ID: 30753822 [TBL] [Abstract][Full Text] [Related]
6. UTX regulates mesoderm differentiation of embryonic stem cells independent of H3K27 demethylase activity. Wang C; Lee JE; Cho YW; Xiao Y; Jin Q; Liu C; Ge K Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15324-9. PubMed ID: 22949634 [TBL] [Abstract][Full Text] [Related]
7. UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development. Shpargel KB; Sengoku T; Yokoyama S; Magnuson T PLoS Genet; 2012 Sep; 8(9):e1002964. PubMed ID: 23028370 [TBL] [Abstract][Full Text] [Related]
8. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma. Yi J; Shi X; Xuan Z; Wu J Cancer Lett; 2021 Feb; 499():188-200. PubMed ID: 33253789 [TBL] [Abstract][Full Text] [Related]
9. JMJD3 as an epigenetic regulator in development and disease. Burchfield JS; Li Q; Wang HY; Wang RF Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001 [TBL] [Abstract][Full Text] [Related]
10. Vitamin C-dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition. Zhang T; Huang K; Zhu Y; Wang T; Shan Y; Long B; Li Y; Chen Q; Wang P; Zhao S; Li D; Wu C; Kang B; Gu J; Mai Y; Wang Q; Li J; Zhang Y; Liang Z; Guo L; Wu F; Su S; Wang J; Gao M; Zhong X; Liao B; Chen J; Zhang X; Shu X; Pei D; Nie J; Pan G J Biol Chem; 2019 Sep; 294(37):13657-13670. PubMed ID: 31341023 [TBL] [Abstract][Full Text] [Related]
11. Catalytic domain-dependent and -independent transcriptional activities of the tumour suppressor histone H3K27 demethylase UTX/KDM6A in specific cancer types. Sun W; Lee KL; Poellinger L; Masai H; Kato H Epigenetics; 2023 Dec; 18(1):2222245. PubMed ID: 37300822 [TBL] [Abstract][Full Text] [Related]
12. The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy. Chen LJ; Xu XY; Zhong XD; Liu YJ; Zhu MH; Tao F; Li CY; She QS; Yang GJ; Chen J Bioorg Chem; 2023 Apr; 133():106409. PubMed ID: 36753963 [TBL] [Abstract][Full Text] [Related]
13. Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization. Kato H; Asamitsu K; Sun W; Kitajima S; Yoshizawa-Sugata N; Okamoto T; Masai H; Poellinger L Oncogene; 2020 Apr; 39(16):3322-3335. PubMed ID: 32071397 [TBL] [Abstract][Full Text] [Related]
14. H3K27me3 demethylase UTX regulates the differentiation of a subset of bipolar cells in the mouse retina. Umutoni D; Iwagawa T; Baba Y; Tsuhako A; Honda H; Aihara M; Watanabe S Genes Cells; 2020 Jun; 25(6):402-412. PubMed ID: 32215989 [TBL] [Abstract][Full Text] [Related]
15. UTX demethylase activity is required for satellite cell-mediated muscle regeneration. Faralli H; Wang C; Nakka K; Benyoucef A; Sebastian S; Zhuang L; Chu A; Palii CG; Liu C; Camellato B; Brand M; Ge K; Dilworth FJ J Clin Invest; 2016 Apr; 126(4):1555-65. PubMed ID: 26999603 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature. Abu-Hanna J; Patel JA; Anastasakis E; Cohen R; Clapp LH; Loizidou M; Eddama MMR Clin Epigenetics; 2022 Aug; 14(1):98. PubMed ID: 35915507 [TBL] [Abstract][Full Text] [Related]
17. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility. Lee SW; Park DY; Kim MY; Kang C Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835 [TBL] [Abstract][Full Text] [Related]
18. The histone demethylase UTX/KDM6A in cancer: Progress and puzzles. Schulz WA; Lang A; Koch J; Greife A Int J Cancer; 2019 Aug; 145(3):614-620. PubMed ID: 30628063 [TBL] [Abstract][Full Text] [Related]